DataMeds AI, Inc.

XNAS

Last traded price · USD

$1.65

+10.76%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 19:32 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $1.49
Volume: 92,472
Day's high: —
Day's low: —

In brief

DataMeds AI, Inc. is a US-listed company listed on Nasdaq, valued at about $7M.
Its shares closed at $1.49 on 4 Nov 2026.
From India you can buy MEDS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy DataMeds AI, Inc. (MEDS) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole MEDS share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade MEDS options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY over 3 months
1 month: −51.5% (SPY −1.6%). 3 months: −46.8% (SPY −0.4%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MEDS, SPY · as of 4 Nov 2026
Short interest at 10.5% of shares outstanding
476.3K shares were sold short at the 15 Oct 2026 settlement, 10.5% of the 4.5M shares outstanding; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average
The 4 Nov 2026 close of $1.49 was 40.1% below its 50-day average ($2.49).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−51.5%

6 months—

1 year—

5 years—

Newswire

About

DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.

Website

Notable moves

October 1, 2026
+28.08%
September 16, 2026
+274.69%
September 15, 2026
+87.22%

DataMeds AI, Inc.

XNAS

Last traded price · USD

$1.65

+10.76%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 19:32 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $1.49
Volume: 92,472
Day's high: —
Day's low: —

In brief

DataMeds AI, Inc. is a US-listed company listed on Nasdaq, valued at about $7M.
Its shares closed at $1.49 on 4 Nov 2026.
From India you can buy MEDS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy DataMeds AI, Inc. (MEDS) shares from India?

Do I need the price of a whole MEDS share to invest?

How much can I invest in US stocks in a year?

Can I trade MEDS options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY over 3 months
1 month: −51.5% (SPY −1.6%). 3 months: −46.8% (SPY −0.4%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MEDS, SPY · as of 4 Nov 2026
Short interest at 10.5% of shares outstanding
476.3K shares were sold short at the 15 Oct 2026 settlement, 10.5% of the 4.5M shares outstanding; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average
The 4 Nov 2026 close of $1.49 was 40.1% below its 50-day average ($2.49).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−51.5%

6 months—

1 year—

5 years—

Newswire

About

Website

Notable moves

October 1, 2026
+28.08%
September 16, 2026
+274.69%
September 15, 2026
+87.22%

DataMeds AI, Inc.

DataMeds AI, Inc. in brief

Behind SPY over 3 months

Short interest at 10.5% of shares outstanding

Below its 50-day average

DataMeds AI, Inc.

DataMeds AI, Inc. in brief

Behind SPY over 3 months

Short interest at 10.5% of shares outstanding

Below its 50-day average